Baseline Ga-68-PSMA-11 PET/CT-Derived Biomarkers from AI-Assisted and Rule-Based Segmentation Predict Survival After Lu-177-PSMA-617 Radioligand Therapy (EANM 2026) - Sep 29, 2026 - Abstract #EP-1170; "QIBs derived from baseline Ga-68-PSMA-11 PET/CT are associated with OS following RLT. Among these, TLQ demonstrated the strongest independent prognostic value and may support patient selection and treatment decisions in mCRPC. Notably, the applied segmentation approach enables reproducible, transparent, and time-efficient biomarker extraction, supporting its potential for clinical implementation."
Biomarker • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Prostate Cancer • Solid Tumor
|
|
A. Szabo; J. Mikolajczak; D. Waldmannstetter; D. Schmidt; J. Moosbauer; D. Weidt; D. Hellwig
|